Berlin Heals Holding AG (Zug, Switzerland) is pleased to announce the appointment of Rob ten Hoedt as the new Chairman of the Board of Directors.
“We are thrilled to welcome someone of Rob ten Hoedt’s caliber to the Board,” said Marko Bagaric, Co-founder and Member of the Board of Directors. “His global impact on healthcare systems and deep expertise in medical technology will positively affect our progress and give us even more momentum for the exciting year ahead.”
Rob ten Hoedt brings more than three decades of global leadership in the medical technology and healthcare sectors, most recently serving as Executive Vice President and President, Global Regions, at Medtronic. Prior to that, he held senior leadership roles at Medtronic SQDM, Vitatron, and Urologix. Rob holds a degree in Commercial Economy from the H.E.A.O. in the Netherlands and a Master’s in Marketing from NIMA Business School. He currently serves as Chairman of the Board of Directors at Medmix and Onward Medical and is a member of the board of Fagron International.
“I am very excited to join the Board of Directors at Berlin Heals Holding AG and to contribute to its revolutionary new therapy in Heart Failure. Together, we will strive to bring the life-changing benefits of the C-MIC device to patients worldwide. A thrilling time lies ahead, and it is an honor to be part of it,” said Mr. ten Hoedt.
“We are delighted to welcome Rob ten Hoedt as our new Chairman of the Board of Directors as we enter a pivotal year for Berlin Heals,” said John Brumfield, Chief Executive Officer of Berlin Heals Holding AG. “His knowledge, leadership experience, and genuine passion for innovation will play an instrumental role in shaping our strategy and driving further growth.”
